Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
15
×
clinical trials
fda
15
×
life sciences
national blog main
boston blog main
boston top stories
national top stories
san francisco blog main
boston
deals
eli lilly
europe blog main
europe top stories
new york top stories
san francisco top stories
indiana blog main
indiana top stories
new york blog main
amgen
detroit blog main
detroit top stories
national
raleigh-durham blog main
raleigh-durham top stories
roche
san diego blog main
san diego top stories
alexion pharmaceuticals
alnylam pharmaceuticals
blueprint medicines
boehringer ingelheim
boulder/denver blog main
boulder/denver top stories
cancer
europe
genentech
investing
novartis
rare disease drugs
What
drug
15
×
fda
medicines
approval
therapeutics
approved
medicine
new
cancer
friday
ipo
marketing
patients
roche
wins
won
brings
candidate
cholesterol
company
deal
developed
developing
disease
eli
intended
lead
lilly
loss
muscle
muscular
nod
oral
pharma
pharmaceuticals
ready
regulatory
research
second
team
Language
unset
15
×
Current search:
drug
×
unset
×
biotech
×
fda
×
@xconomy.com
3 years ago
FDA Panel Vote Weighs in Favor of Alkermes Psyche Drug, With Caveats
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
FDA Rejects Boehringer Ingelheim, Eli Lilly Drug for Type 1 Diabetes
@xconomy.com
4 years ago
Esperion’s Combo Pill for Lowering Cholesterol Levels Wins FDA Nod
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
4 years ago
Amgen’s Osteoporosis Drug Wins European Nod, With a Heart Warning
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
4 years ago
FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades
@xconomy.com
4 years ago
UCB Stakes Out Autoimmune Territory With $2.1B Deal for Ra Pharma
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds